NEXMED INC
10QSB, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: NEXMED INC, 10QSB, 2000-11-14
Next: ACE COMM CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Form 10-QSB
for the Quarterly Period Ended September 30, 2000, and is qualified in its
entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      38,573,265
<SECURITIES>                                 1,586,878
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            41,125,719
<PP&E>                                       1,155,761
<DEPRECIATION>                               (311,590)
<TOTAL-ASSETS>                              41,969,890
<CURRENT-LIABILITIES>                          479,612
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        24,896
<OTHER-SE>                                  41,465,382
<TOTAL-LIABILITY-AND-EQUITY>                41,969,890
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                78,866
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             735,552
<INCOME-PRETAX>                            (5,550,020)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (5,550,020)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (5,550,020)
<EPS-BASIC>                                   (0.28)
<EPS-DILUTED>                                   (0.28)






</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission